These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8128843)

  • 1. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.
    Nordberg A
    Acta Neurol Scand Suppl; 1993; 149():62-5. PubMed ID: 8128843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.
    Nordberg A; Lundqvist H; Hartvig P; Andersson J; Johansson M; Hellstrŏm-Lindahi E; Långström B
    Dement Geriatr Cogn Disord; 1997; 8(2):78-84. PubMed ID: 9065319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.
    Nordberg A; Lilja A; Lundqvist H; Hartvig P; Amberla K; Viitanen M; Warpman U; Johansson M; Hellström-Lindahl E; Bjurling P
    Neurobiol Aging; 1992; 13(6):747-58. PubMed ID: 1491741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET studies and cholinergic therapy in Alzheimer's disease.
    Nordberg A
    Rev Neurol (Paris); 1999; 155 Suppl 4():S53-63. PubMed ID: 10637939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies in Alzheimer patients with positron emission tomography.
    Nordberg A
    Behav Brain Res; 1993 Nov; 57(2):215-24. PubMed ID: 7906947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities.
    Nordberg A; Amberla K; Shigeta M; Lundqvist H; Viitanen M; Hellström-Lindahl E; Johansson M; Andersson J; Hartvig P; Lilja A; Långström B; Winblad B
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):228-37. PubMed ID: 9772028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic therapy in dementia.
    Whitehouse PJ
    Acta Neurol Scand Suppl; 1993; 149():42-5. PubMed ID: 8128838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG regional changes during long-term treatment with tetrahydroaminoacridine (THA) in Alzheimer's disease.
    Shigeta M; Persson A; Viitanen M; Winblad B; Nordberg A
    Acta Neurol Scand Suppl; 1993; 149():58-61. PubMed ID: 8128842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of neurotransmitter changes in Alzheimer's disease.
    Nordberg A
    Ann N Y Acad Sci; 1993 Sep; 695():27-33. PubMed ID: 7902055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease.
    Minthon L; Nilsson K; Edvinsson L; Wendt PE; Gustafson L
    Dementia; 1995; 6(5):245-51. PubMed ID: 8528370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
    Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
    Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
    Riekkinen P; Riekkinen M; Soininen H; Kuikka J; Laakso M; Riekkinen P
    Neuroreport; 1997 May; 8(8):1845-9. PubMed ID: 9223063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease.
    Gustafson L
    Acta Neurol Scand Suppl; 1993; 149(Rand):39-41. PubMed ID: 8128836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat.
    Zhang X; Tian JY; Svensson AL; Gong ZH; Meyerson B; Nordberg A
    J Neural Transm (Vienna); 2002 Mar; 109(3):377-92. PubMed ID: 11956958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data.
    Amberla K; Nordberg A; Viitanen M; Winblad B
    Acta Neurol Scand Suppl; 1993; 149():55-7. PubMed ID: 8128841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
    Kadir A; Darreh-Shori T; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2007 May; 191(4):1005-14. PubMed ID: 17310387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?
    Nilsson L; Adem A; Hardy J; Winblad B; Nordberg A
    J Neural Transm; 1987; 70(3-4):357-68. PubMed ID: 3681290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anticholinesterase THB013: biochemical and behavioural studies.
    Adem A; Mohammed AH; Winblad B; Henriksson BE
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):139-48. PubMed ID: 7893376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple effects of tetrahydroaminoacridine on the cholinergic system: biochemical and behavioural aspects.
    Adem A; Mohammed AK; Winblad B
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):113-28. PubMed ID: 2222779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.